Form ARS PACIFIC BIOSCIENCES OF For: Dec 31
http://archive.fast-edgar.com/20240429/A2ZZO22CZ22RN2B2222M22Z2AMWGZZ2S4T62
Filed on: April 29, 2024
Form 497K JNL SERIES TRUST
http://archive.fast-edgar.com/20240429/AR2IP222Z222S2G2222C22Y2QQRGZ522B262
Filed on: April 29, 2024
Form 6-K Vale S.A. For: Jun 30
United States
Securities and Exchange Commission
Washington, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
of the
Securities Exchange Act of 1934
For the month of
April 2024
Vale S.A.
Praia de Botafogo nº 186, 18º andar, Botafogo 22250-145 Rio de Janeiro, RJ, Brazil
(Address of principal executive office)
(Indicate by check mark whether the registrant... (continue reading...)
Form 10-K/A UroGen Pharma Ltd. For: Dec 31
true
0001668243
0001668243
2023-01-01
2023-12-31
0001668243
2023-06-30
0001668243
2024-04-22
iso4217:USD
xbrli:shares
--12-31FY2023
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-K/A
(Amendment No. 1)
(Mark One)
☑
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended... (continue reading...)
Form DEFR14A Katapult Holdings, Inc.
UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549___________________________________SCHEDULE 14AProxy Statement Pursuant to Section 14(a) ofthe Securities Exchange Act of 1934(Amendment No. 1)___________________________________ Filed by the Registrant ☒Filed by a Party other than the Registrant ☐Check the appropriate box:☐Preliminary Proxy Statement☐Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))☐Definitive Proxy... (continue reading...)
More SEC Filings
View Older Stories-
Form 6-K KONINKLIJKE PHILIPS NV For: Apr 29
-
Form 8-K PETMED EXPRESS INC For: Apr 29
-
Form DEFA14A PACIFIC BIOSCIENCES OF
-
Form DEF 14A PACIFIC BIOSCIENCES OF For: Jun 18
-
Form 8-K Sight Sciences, Inc. For: Apr 26
-
Form 6-K Electrovaya Inc. For: Apr 29
-
Form 1-K Emerging Fuels Technolog For: Dec 31
-
Form 6-K YS Biopharma Co., Ltd. For: Apr 29
-
Form 424B5 UMB FINANCIAL CORP
-
Form DEFA14A GRAFTECH INTERNATIONAL
-
Form 497K JNL SERIES TRUST
-
Form 8-K Douglas Elliman Inc. For: Apr 26
-
Form 8-K Owens Corning For: Apr 29
-
Form 25-NSE John Hancock Tax-Advanta Filed by: NEW YORK STOCK EXCHANGE LLC
-
Form 10-K/A CalciMedica, Inc. For: Dec 31
-
Form 10-K/A Altisource Asset Managem For: Dec 31
-
Form ARS Vital Farms, Inc. For: Dec 31
-
Form 8-K CPS TECHNOLOGIES CORP/DE For: Apr 25
-
Form 8-K Scorpius Holdings, Inc. For: Apr 29
-
Form 6-K Valens Semiconductor For: Apr 29
-
Form 485BPOS DAVIS SERIES INC
-
Form 8-K OGLETHORPE POWER CORP For: Apr 29
-
Form 8-K ON SEMICONDUCTOR CORP For: Apr 29
-
Form 10-D World Omni Automobile For: Mar 31
-
Form ARS Carisma Therapeutics For: Dec 31
-
Form D/A Lantah Co
-
Form DEFA14A Vital Farms, Inc.
-
Form 20-F Tuniu Corp For: Dec 31
-
Form 8-K COLLEGIUM PHARMACEUTICAL For: Apr 26
-
Form DEFA14A C4 Therapeutics, Inc.
-
Form 425 UMB FINANCIAL CORP Filed by: UMB FINANCIAL CORP
-
Form 10-Q NEWMONT Corp /DE/ For: Mar 31
-
Form 497K JNL SERIES TRUST
-
Form 10-K Namliong SkyCosmos, Inc. For: Dec 31
-
Form 6-K DAQO NEW ENERGY CORP. For: Apr 29
-
Form DEF 14A C4 Therapeutics, Inc. For: Apr 29
-
Form ARS Compass Therapeutics, For: Dec 31
-
Form DEF 14A Carisma Therapeutics For: Jun 13
-
Form 497K T. Rowe Price Equity
-
Form 497 T. Rowe Price Equity
-
Form 425 California BanCorp Filed by: Southern California Bancorp \ CA
-
Form DEFA14A Compass Therapeutics,
-
Form 8-K California BanCorp For: Apr 29
-
Form 20-F SunCar Technology Group For: Dec 31
-
Form ARS NOVAVAX INC For: Dec 31
-
Form DEF 14A Vital Farms, Inc. For: Jun 12
-
Form 1-K Sugarfina Corp For: Dec 31
-
Form 8-K Southern California Banc For: Apr 29
-
Form 6-K Enlivex Therapeutics For: Apr 29
-
Form 424B2 ROYAL BANK OF CANADA